Motor nervous pathway function is impaired after treatment of childhood acute lymphoblastic leukemia: A study with motor evoked potentials

Medical and Pediatric Oncology

Volumn 36, Issue 3, 2001, Pages 345-351

  Harila Saari, Arja H ^a,b   Huuskonen, Usko E J ^a   Tolonen, Uolevi ^a   Vainionpää, Leena K ^a   Lanning, B Marjatta ^a  

^a UNIVERSITY OF OULU   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Acute lymphoblastic leukemia; Central nervous system; Children motor evoked potentials; Magnetic stimulation; Peripheral nerve

Indexed keywords

METHOTREXATE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BRACHIAL PLEXUS; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; DEMYELINATION; DYSKINESIA; EVOKED MUSCLE RESPONSE; FEMALE; HUMAN; MAGNETIC STIMULATION; MALE; MOTOR DYSFUNCTION; MOTOR NERVE; NEUROTOXICITY; PRIORITY JOURNAL; TENDON REFLEX;

ADOLESCENT; ANTINEOPLASTIC AGENTS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; EVOKED POTENTIALS, MOTOR; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; METHOTREXATE; MOTOR NEURON DISEASE; NEUROLOGIC EXAMINATION; VINCRISTINE;

EID: 0035089633     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.1084     Document Type: Article

References (39)

1. Neurotoxicity due to central nervous system therapy for childhood leukemia
2. A longitudinal magnetic resonance imaging study of the brain in survivors of childhood acute lymphoblastic leukemia
3. Long-term neuropsychologic sequelae of childhood leukemia: Comparison of two CNS prophylactic regimens
4. Electrophysiological signs of neurocognitive deficits in long-term leukemia survivors
5. Neurophysiological basis of cognitive deficits in long-term suvivors of childhood cancer
6. Excessive spinal cord toxicity from intensive central nervous system-directed therapies
7. Demyelination and single-carbon transfer pathway metabolites during the treatment of acute lymphoblastic leukemia: CSF studies
8. Nerve lesions after therapy for childhood acute lymphoblastic leukemia
9. Vincristine-induced neuropathy: A clinical study of fifty leukemic patients
10. Vincristine neuropathy. Clinical and electrophysiological observations
11. Clinical neurological findings of children with acute lymphoblastic leukaemia at diagnosis and during treatment
12. Vincristine neuropathy: An electrophysiological and histological study
13. Vincristine therapy for children with acute lymphoblastic leukemia impairs conduction in the entire peripheral nerve
14. Transcranial motor evoked potentials
15. A population-based study of childhood acute lymphoblastic leukemia diagnosed from July 1981 through June 1985 in the five Nordic countries. Incidence, patient characteristics and treatment results
16. Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83)
17. Minor changes on cranial MRI during treatment in children with acute lymphoblastic leukaemia
18. Nuclear magnetic resonance abnormalities of the cerebral white matter in children with acute lymphoblastic leukemia and malignant lymphoma during and after central nervous system prophylactic treatment with intrathecal methotrexate
19. Transient white matter changes on MR images in children undergoing chemotherapy for acute lymphocytic leukemia: Correlation with neuropsychologic deficiencies
20. Paraplegia following intrathecal chemotherapy: Neuropathologic findings and elevation of myelin basic protein
21. Acute fatal myeloencephalopathy after combined intrathecal chemotherapy in a child with acute lymphoblastic leukemia
22. Paraplegia following intrathecal chemotherapy
23. Abnormal visual-evoked potentials in leukemic children after cranial radiation
24. Visual-evoked potentials in long-term survivors of acute lymphoblastic leukemia in childhood
25. Neurophysiological findings in long-term survivors of acute lymphoblastic leukaemia in childhood treated with the BFM protocol 81 SR-A/B
26. Attentional deficits in long-term survivors of childhood acute lymphoblastic leukemia (ALL)
27. P3φφ as indicator of effects of prophylactic cranial radiation
28. P300 abnormalities in long-time survivors of acute lymphoblastic leukemia in childhood - Side effects of CNS prophylaxis?
29. Central nervous system pharmacology of antileukemic drugs
30. Cytarabine and neurologic toxicity
31. Progressive ascending paralysis following administration of intrathecal and intravenous cytosine arabinoside. A Pediatric Oncology Group study
32. Bulbar and pseudobulbar palsy complicating therapy with high-dose cytosine arabinoside in children with leukemia
33. Seizures following intrathecal cytosine arabinoside in young children with acute lymphoblastic leukemia
34. The neuromyopathy of vincristine in man. Clinical, electrophysiological and pathological studies
35. Facilitatory effect of thinking about movement on motor-evoked potentials to transcranial magnetic stimulation of the brain
36. Improvement of amplitude variability of motor evoked potentials in multiple sclerosis patients and in healthy subjects
37. Neurotoxicology of vincristine in the cat. Morphological study
38. Clinical applications of motor evoked potentials